Literature DB >> 23795429

Payment by results: are we missing something?

Mohammad Shahid1, Alistair Tindall.   

Abstract

PURPOSE: Payment by results (PbR) was introduced to reward hospitals for productivity. In orthopaedic clinics there is a separate tariff for two procedures: removal of sutures (ROS) and attention to dressing (AD). The Trust claims a fee each time these have been performed. The purpose of this paper is to look at how many of these procedures were performed in an outpatient setting but were not claimed for because of poor documentation. DESIGN/METHODOLOGY/APPROACH: A retrospective study was performed analysing all orthopaedics clinics occurring in one month. After each consultation the clinician completes a coding pro forma and dictates a clinic letter. The pro forma contains a list of the orthopaedic procedures attracting a tariff and used for coding. A comparison was made between what was documented on the pro forma and the clinic letter to see how many times ROS and AD were done.
FINDINGS: A total of 72 letters were extracted which contained ROS and AD. Only one of the ROS was documented on the pro forma and subsequently captured by the coders. In one month the Trust failed to claim 9,838 pounds. Annually this equates to a revenue loss totaling 118,056 pounds. Practical implications - Current coding practice is substandard. To maintain financial security Trusts must improve their coding policies as a matter of urgency. ORIGINALITY/VALUE: The paper demonstrates clearly that hospital trusts are losing out financially from this suboptimal practice.

Entities:  

Mesh:

Year:  2013        PMID: 23795429     DOI: 10.1108/09526861311319609

Source DB:  PubMed          Journal:  Int J Health Care Qual Assur        ISSN: 0952-6862


  1 in total

1.  Surgeon involvement in clinical coding to improve data accuracy and remuneration in a shoulder and elbow unit.

Authors:  Steven Kyriacou; David Butt; Will Rudge; Deborah Higgs; Mark Falworth; Addie Majed
Journal:  Shoulder Elbow       Date:  2021-02-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.